Assyro AI
FDA 483 Database

FDA Form 483s Issued in February 2025

Every published Form FDA 483 issued in February 2025, drawn from the FDA OII FOIA Electronic Reading Room. Each row links to the FDA source record.

13

Published 483s in February 2025

13

Distinct firms

Form 483s issued in February 2025

Shouguang Fukang Pharmaceutical Co., Ltd.FDA
FEI
3003941038
Issued
Feb 21, 2025
Establishment
API (animal origin) Manufacturer
Location
China
Ajinomoto Company Inc.FDA
FEI
3002806336
Issued
Feb 21, 2025
Establishment
API (animal origin) Manufacturer
Location
Japan
Somerset Therapeutics Private LimitedFDA
FEI
3003821988
Issued
Feb 21, 2025
Establishment
Sterile Drug Manufacturer
Location
India
Orchid Pharma LimitedFDA
FEI
3003747558
Issued
Feb 18, 2025
Establishment
API (animal origin) Manufacturer
Location
India
Patheon Italia S.p.A.FDA
FEI
3004110157
Issued
Feb 18, 2025
Establishment
Drug Manufacturer
Location
Italy
Hikal LimitedFDA
FEI
3003560263
Issued
Feb 7, 2025
Establishment
API and Intermediate Manufacturer
Location
India
Micro Labs LimitedFDA
FEI
3004495158
Issued
Feb 7, 2025
Establishment
Finished Drug Product Manufacturer
Location
India
A2A integrated Logistics IncFDA
FEI
3018755991
Issued
Feb 24, 2025
Establishment
Drug Wholesale Distributor
Location
United States
BlendHouse Allerton LLCFDA
FEI
1921383
Issued
Feb 20, 2025
Establishment
Manufacturer
Location
Pennsylvania, United States
Meds for VetsFDA
FEI
3003829708
Issued
Feb 21, 2025
Establishment
Producer of Sterile and Non Sterile Drug Products
Location
Utah, United States
Eagle Pharma Outsourcing LLCFDA
FEI
3011688532
Issued
Feb 27, 2025
Establishment
Outsourcing Facility
Location
Alabama, United States
Revive Rx LLCFDA
FEI
3016710945
Issued
Feb 7, 2025
Establishment
Producer of Sterile and Non Sterile Drug Products
Location
Texas, United States
Palmetto Isotopes LLCFDA
FEI
3016492204
Issued
Feb 28, 2025
Establishment
Nuclear Pharmacy
Location
South Carolina, United States

Other months in 2025

Back to the FDA 483 Database